Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Gastroenterology. 2017 Nov;153(5):1284-1294.e1. doi: 10.1053/j.gastro.2017.07.019. Epub 2017 Jul 21.

PMID:
28739282
2.

Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.

Ridtitid W, DeWitt JM, Schmidt CM, Roch A, Stuart JS, Sherman S, Al-Haddad MA.

Gastrointest Endosc. 2016 Sep;84(3):436-45. doi: 10.1016/j.gie.2016.02.008. Epub 2016 Feb 18.

3.

Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.

Han Y, Lee H, Kang JS, Kim JR, Kim HS, Lee JM, Lee KB, Kwon W, Kim SW, Jang JY.

Gastroenterology. 2018 Feb;154(3):576-584. doi: 10.1053/j.gastro.2017.10.013. Epub 2017 Oct 23.

PMID:
29074452
4.

Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.

Kwong WT, Lawson RD, Hunt G, Fehmi SM, Proudfoot JA, Xu R, Giap A, Tang RS, Gonzalez I, Krinsky ML, Savides TJ.

Dig Dis Sci. 2015 Sep;60(9):2800-6. doi: 10.1007/s10620-015-3679-8. Epub 2015 Apr 30.

PMID:
25924899
5.

Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.

Kim TH, Woo YS, Chon HK, Hwang JH, Yoo KS, Lee WJ, Lee KH, Lee JK, Dong SH, Park CH, Park ET, Moon JH, Kim HG, Cho KB, Kim HJ, Lee SO, Cheon YK, Lee JM, Park JW, Kim MH.

Gut Liver. 2018 Sep 15;12(5):583-590. doi: 10.5009/gnl17582.

6.

Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.

Nguyen AH, Toste PA, Farrell JJ, Clerkin BM, Williams J, Muthusamy VR, Watson RR, Tomlinson JS, Hines OJ, Reber HA, Donahue TR.

J Gastrointest Surg. 2015 Feb;19(2):258-65. doi: 10.1007/s11605-014-2693-z. Epub 2014 Nov 6.

7.

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.

Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, Levy P, Partelli S, Suleiman SL, Banks PA, Ahmed N, Chari ST, Fernández-Del Castillo C, Falconi M.

Gut. 2017 Mar;66(3):495-506. doi: 10.1136/gutjnl-2015-310162. Epub 2016 Jan 7.

PMID:
26743012
8.

Does cyst growth predict malignancy in branch duct intraductal papillary mucinous neoplasms? Results of a large multicenter experience.

El Chafic A, El Hajj II, DeWitt J, Schmidt CM, Siddiqui A, Sherman S, Aggarwal A, Al-Haddad M.

Dig Liver Dis. 2018 Sep;50(9):961-968. doi: 10.1016/j.dld.2018.04.022. Epub 2018 Apr 27.

PMID:
29866630
9.

Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.

Girometti R, Pravisani R, Intini SG, Isola M, Cereser L, Risaliti A, Zuiani C.

World J Gastroenterol. 2016 Nov 21;22(43):9562-9570.

10.

Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.

Sawai Y, Yamao K, Bhatia V, Chiba T, Mizuno N, Sawaki A, Takahashi K, Tajika M, Shimizu Y, Yatabe Y, Yanagisawa A.

Endoscopy. 2010 Dec;42(12):1077-84. doi: 10.1055/s-0030-1255971. Epub 2010 Nov 30. Erratum in: Endoscopy. 2011 Jan;43(1):79.

PMID:
21120776
11.

Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.

Ohno E, Itoh A, Kawashima H, Ishikawa T, Matsubara H, Itoh Y, Nakamura Y, Hiramatsu T, Nakamura M, Miyahara R, Ohmiya N, Ishigami M, Katano Y, Goto H, Hirooka Y.

Pancreas. 2012 Aug;41(6):855-62. doi: 10.1097/MPA.0b013e3182480c44.

PMID:
22481289
12.

Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.

Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Pancreas. 2010 Mar;39(2):232-6. doi: 10.1097/MPA.0b013e3181bab60e.

PMID:
19752768
13.

Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Bae SY, Lee KT, Lee JH, Lee JK, Lee KH, Rhee JC.

Dig Liver Dis. 2012 Mar;44(3):257-60. doi: 10.1016/j.dld.2011.09.010. Epub 2011 Oct 24.

PMID:
22030480
14.

Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study.

Kobayashi G, Fujita N, Maguchi H, Tanno S, Mizuno N, Hanada K, Hatori T, Sadakari Y, Yamaguchi T, Tobita K, Doi R, Yanagisawa A, Tanaka M; Working Group for the Natural History of IPMN of the Japan Pancreas Society.

Pancreas. 2014 May;43(4):532-8. doi: 10.1097/MPA.0000000000000080.

15.

Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.

Kayal M, Luk L, Hecht EM, Do C, Schrope BA, Chabot JA, Gonda TA.

AJR Am J Roentgenol. 2017 Aug;209(2):320-326. doi: 10.2214/AJR.16.17249. Epub 2017 Jun 7.

PMID:
28590817
16.

The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.

Khannoussi W, Vullierme MP, Rebours V, Maire F, Hentic O, Aubert A, Sauvanet A, Dokmak S, Couvelard A, Hammel P, Ruszniewski P, Lévy P.

Pancreatology. 2012 May-Jun;12(3):198-202. doi: 10.1016/j.pan.2012.03.056. Epub 2012 Mar 20.

PMID:
22687372
17.

Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.

Mukewar S, de Pretis N, Aryal-Khanal A, Ahmed N, Sah R, Enders F, Larson JJ, Levy MJ, Takahashi N, Topazian M, Pearson R, Vege SS, Chari ST.

Gut. 2017 Oct;66(10):1811-1817. doi: 10.1136/gutjnl-2016-311615. Epub 2016 Jul 7.

PMID:
27390303
18.

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.

Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, Castillo CF, Sahani D, Bounds B, Forcione D, Brugge WR, Pitman MB.

Ann Surg. 2011 Dec;254(6):977-83. doi: 10.1097/SLA.0b013e3182383118.

19.

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.

Tang RS, Weinberg B, Dawson DW, Reber H, Hines OJ, Tomlinson JS, Chaudhari V, Raman S, Farrell JJ.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):815-9; quiz 719. doi: 10.1016/j.cgh.2008.04.005.

PMID:
18602036
20.

Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms.

Rosenblatt R, Dorfman V, Epelboym I, Poneros JM, Sethi A, Lightdale C, Woo Y, Gress FG, Allendorf JD, Schrope BA, Chabot JA, Gonda TA.

Pancreas. 2015 Apr;44(3):478-83. doi: 10.1097/MPA.0000000000000264.

PMID:
25411806

Supplemental Content

Support Center